198 related articles for article (PubMed ID: 22919556)
41. Comparison of elastography based on transvaginal ultrasound and MRI in assessing parametrial invasion of cervical cancer.
Ma X; Li Q; Wang JL; Shao J; Zhu YC; Ding W; Zhang HS; Wang HY; Shen JK
Clin Hemorheol Microcirc; 2017; 66(1):27-35. PubMed ID: 28211804
[TBL] [Abstract][Full Text] [Related]
42. Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer?
Marnitz S; Köhler C; Roth C; Füller J; Hinkelbein W; Schneider A
Gynecol Oncol; 2005 Dec; 99(3):536-44. PubMed ID: 16126259
[TBL] [Abstract][Full Text] [Related]
43. Diagnostic Value of Diffusion-Weighted Imaging with Background Body Signal Suppression (DWIBS) for the Pre-Therapeutic Loco-Regional Staging of Cervical Cancer: A Feasibility and Interobserver Reliability Study.
Schleder S; May M; Scholz C; Dinkel J; Strotzer Q; Einspieler I; Dollinger M; Schreyer AG; Grassinger J; Schicho A
Curr Oncol; 2023 Jan; 30(1):1164-1173. PubMed ID: 36661738
[TBL] [Abstract][Full Text] [Related]
44. Incremental prognostic value of MRI in the staging of early cervical cancer: a prospective study and review of the literature.
Bourgioti C; Chatoupis K; Rodolakis A; Antoniou A; Tzavara C; Koutoulidis V; Moulopoulos LA
Clin Imaging; 2016; 40(1):72-8. PubMed ID: 26459788
[TBL] [Abstract][Full Text] [Related]
45. Assessment of Parametrial Response by Growth Pattern in Patients With International Federation of Gynecology and Obstetrics Stage IIB and IIIB Cervical Cancer: Analysis of Patients From a Prospective, Multicenter Trial (EMBRACE).
Yoshida K; Jastaniyah N; Sturdza A; Lindegaard J; Segedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz I; Haie-Meder C; Sasaki R; Pötter R
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):788-96. PubMed ID: 26530747
[TBL] [Abstract][Full Text] [Related]
46. Stage Ib, IIa, and IIb cervix cancer, postsurgical staging, and prognosis.
Matsuyama T; Inoue I; Tsukamoto N; Kashimura M; Kamura T; Saito T; Uchino H
Cancer; 1984 Dec; 54(12):3072-7. PubMed ID: 6498784
[TBL] [Abstract][Full Text] [Related]
47. MRI and PET scans for primary staging and detection of cervical cancer recurrence.
Liyanage SH; Roberts CA; Rockall AG
Womens Health (Lond); 2010 Mar; 6(2):251-67; quiz 268-9. PubMed ID: 20187730
[TBL] [Abstract][Full Text] [Related]
48. Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer.
Wagenaar HC; Trimbos JB; Postema S; Anastasopoulou A; van der Geest RJ; Reiber JH; Kenter GG; Peters AA; Pattynama PM
Gynecol Oncol; 2001 Sep; 82(3):474-82. PubMed ID: 11520143
[TBL] [Abstract][Full Text] [Related]
49. Prognostic significance of parametrial extension in patients with cervical carcinoma Stages IB, IIA, and IIB. A study of 628 cases treated by radical hysterectomy and lymphadenectomy with or without postoperative irradiation.
Inoue T; Okumura M
Cancer; 1984 Oct; 54(8):1714-9. PubMed ID: 6478409
[TBL] [Abstract][Full Text] [Related]
50. Preoperative staging of cervical carcinoma with MR imaging: a reappraisal of diagnostic accuracy and pitfalls.
Sheu MH; Chang CY; Wang JH; Yen MS
Eur Radiol; 2001; 11(9):1828-33. PubMed ID: 11511909
[TBL] [Abstract][Full Text] [Related]
51. [Invasive carcinoma of the cervix uteri (stage IB-IIB): evaluation using magnetic resonance].
Sironi S; Belloni C; Taccagni L; Del Maschio A
Radiol Med; 1990 Sep; 80(3):314-20. PubMed ID: 2236692
[TBL] [Abstract][Full Text] [Related]
52. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.
Wright JD; Matsuo K; Huang Y; Tergas AI; Hou JY; Khoury-Collado F; St Clair CM; Ananth CV; Neugut AI; Hershman DL
Obstet Gynecol; 2019 Jul; 134(1):49-57. PubMed ID: 31188324
[TBL] [Abstract][Full Text] [Related]
53. MRI of cervical cancer with a surgical perspective: staging, prognostic implications and pitfalls.
Balcacer P; Shergill A; Litkouhi B
Abdom Radiol (NY); 2019 Jul; 44(7):2557-2571. PubMed ID: 30903231
[TBL] [Abstract][Full Text] [Related]
54. Prospective comparison between clinical and CT staging in primary cervical carcinoma.
Walsh JW; Goplerud DR
AJR Am J Roentgenol; 1981 Nov; 137(5):997-1003. PubMed ID: 6975028
[TBL] [Abstract][Full Text] [Related]
55. Indication and efficacy of radiation therapy following radical surgery in patients with stage IB to IIB cervical cancer.
Okada M; Kigawa J; Minagawa Y; Kanamori Y; Shimada M; Takahashi M; Oishi T; Terakawa N
Gynecol Oncol; 1998 Jul; 70(1):61-4. PubMed ID: 9698475
[TBL] [Abstract][Full Text] [Related]
56. Integrated pre-surgical diagnostic algorithm to define extent of disease in cervical cancer.
Sozzi G; Berretta R; Fiengo S; Ferreri M; Giallombardo V; Finazzo F; Messana D; Capozzi VA; Colacurci N; Scambia G; Chiantera V
Int J Gynecol Cancer; 2020 Jan; 30(1):16-20. PubMed ID: 31645425
[TBL] [Abstract][Full Text] [Related]
57. The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy.
Chen SW; Liang JA; Yang SN; Ko HL; Lin FJ
Radiother Oncol; 2003 Apr; 67(1):69-76. PubMed ID: 12758242
[TBL] [Abstract][Full Text] [Related]
58. FIGO Classification 2018: Validation Study in Patients With Locally Advanced Cervix Cancer Treated With Chemoradiation.
Raut A; Chopra S; Mittal P; Patil G; Mahantshetty U; Gurram L; Swamidas J; Ghosh J; Gulia S; Popat P; Deodhar K; Maheshwari A; Gupta S
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1248-1256. PubMed ID: 32681859
[TBL] [Abstract][Full Text] [Related]
59. Comparison of computed tomography with magnetic resonance imaging for imaging-based clinical target volume contours in cervical cancer brachytherapy.
Zolciak-Siwinska A; Kowalczyk A; Sikorska K; Bijok M; Michalski W; Gruszczynska E
Brachytherapy; 2018; 17(4):667-672. PubMed ID: 29764769
[TBL] [Abstract][Full Text] [Related]
60. Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer.
Sala E; Micco M; Burger IA; Yakar D; Kollmeier MA; Goldman DA; Gonen M; Park KJ; Abu-Rustum NR; Hricak H; Vargas HA
Int J Gynecol Cancer; 2015 Oct; 25(8):1461-7. PubMed ID: 26397068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
